Skip to main content

Advertisement

Log in

Generation of killer lymphocytes in vitro against human autologous leukemia cells with leukemic blasts and BCG extract

  • Original Articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

Acute lymphoblastic leukemia patients under 18 years of age were studied to determine the ability of their remission lymphocytes to kill autologous leukemic blasts (ALB) following in vitro sensitization with their leukemic cells and/or soluble extract of BCG (BCG-SE). Remission lymphocytes, when cultured together with the mitomycin-treated ALB, became significantly lytic for ALB but not for autologous remission lymphocytes. The ALB were usually immunogenic at low concentrations and no cytotoxic lymphocytes were generated at a ratio of 1:1 of responding lymphocytes to stimulating leukemic cells. T-leukemic cells appeared to immunize more effectively than null-cell leukemic cells. In some cases, when ALB alone could not generate killer lymphocytes (KL) the combination of ALB and BCG-SE induced more intense cytotoxicity than was induced by BCG-SE alone. In a few other cases, the addition of BCG-SE to mixed lymphocyte leukemic cell cultures potentiated the immunization of lymphocytes by leukemic cells. Inhibition of cytotoxicity induction was noted in one case when remission lymphocytes were cultured together with ALB and BCG-SE. Leukemic cellssensitized lymphocytes from some cancer patients and normal persons were cytotoxic to several but not all patients' leukemic cells tested. Nylon wool-nonadherent, non-E-rosette-forming, and E-rosette-forming cells became cytotoxic following in vitro stimulation with autologous leukemic cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bonnard, G. D., Manders, E. K., Campbell, D. A., Herberman, R. B., Collins, M. J.: Immunosuppressive activity of a subline of the mouse EL-4 lymphoma: evidence for minute virus of mice causing inhibition. J. Exp. Med. 143, 187 (1976)

    Google Scholar 

  2. Burton, R. C., Warner, N. L.: In vitro induction of tumor-specific immunity. IV. Specific adoptive immunotherapy with cytotoxic T cells induced in vitro to plasmacytoma antigens. Cancer Immunol. Immunother. 2, 91 (1977)

    Google Scholar 

  3. Burton, R., Thompson, J., Warner, N. L.: In vitro induction of tumor-specific immunity. 1. Development of optimal conditions for induction and assay of cytotoxic lymphocytes. J. Immunol. Methods 8, 133 (1975)

    Google Scholar 

  4. Deckers, P. J., Davis, R. C., Parker, G. A., Mannick, J. A.: The effect of tumor size on concomitant tumor immunity. Cancer Res. 33, 33 (1973)

    Google Scholar 

  5. Ezaki, K., Hersh, E. M., Keating, M., Dyr, S., Hollinshead, A., McCredie, K. B., Mavlight, G. M., Gutterman, J. U.: Active specific immunization with allogeneic leukemia associated antigens or irradiated allogeneic leukemia cells in acute leukemia. Cancer 41, 70 (1978)

    Google Scholar 

  6. Friedman, H., Ceglowski, W. S.: Effects of immunostimulating and immunosuppressive agents. In: The role of immunologic factors in viral and oncogenic processes, p. 187. Baltimore: Johns Hopkins University Press 1974

    Google Scholar 

  7. Golub, S. H., Morton, D. L.: Sensitization of lymphocytes in vitro against human melanoma-associated antigens. Nature 251, 161 (1974)

    Google Scholar 

  8. Gutterman, J. U., Mavliglit, G., McBride, C., Frei, E., IIII, Freireich, E. J., Hersh, E. M.: Active immunotherapy with BCG for recurrent malignant melanoma. Lancet 1973 I, 1208

    Google Scholar 

  9. Klein, G., Sjogren, H. O., Klein, E. et al.: Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host. Cancer Res. 20, 1561 (1960)

    Google Scholar 

  10. Ludak, R. L., Raidt, D. J.: Cellular immune response against tumor cells. 1. In vitro immunization of allogeneic and syngeneic mouse spleen cell suspensions against DBA mastocytoma cells. Cell. Immunol. 9, 60 (1973)

    Google Scholar 

  11. Mathé, G., Amiel, J. L., Schwarzenburg, L., Schneider, M., Cattan, A., Schlumberger, J. R., Hayat, A., DeVassal, F.: Active immunotherapy for acute lymphoblastic leukemia. Lancet 1969 I, 697

    Google Scholar 

  12. Morton, D. L., Eilber, F. R., Holmes, E. C., Hunt, J. S., Ketchan, A. S., Silverstein, M. S., Parks, F. F.: BCG immunotherapy of malignant melanoma. Surgery 68, 158 (1974)

    Google Scholar 

  13. Rollinghoff, M., Wagner, H.: In vivo protection against murine plasma cell tumor growth by in vitro activated syngeneic lymphocytes. J. Natl. Cancer Inst. 51, 1317 (1973)

    Google Scholar 

  14. Sharma, B.: In vitro lymphocyte immunization to cultured human tumor cells: Parameters for generation of cytotoxic lymphocytes. J. Natl. Cancer Inst. 57, 743 (1976)

    Google Scholar 

  15. Sharma, B.: In vitro immunization against human tumor cells with tumor cell fractions. Cancer Res. 37, 4660 (1977)

    Google Scholar 

  16. Sharma, B., Terasaki, P. I.: In vitro immunization to cultured human tumor cells. Cancer Res. 34, 115 (1974)

    Google Scholar 

  17. Sharma, B., Kohashi, O., Mickey, M. R., Terasaki, P. I.: Effect of water-soluble adjuvants on in vitro lymphocyte immunization. Cancer. Res. 35, 666 (1975)

    Google Scholar 

  18. Sharma, B., Tubergen, D. G., Minden, P., Brunda, M. J.: In vitro immunization against human tumor cells with bacterial extracts. Nature 267, 845 (1977)

    Google Scholar 

  19. Smith, H. G., Harmal, R. P., Hanna, M. G., Jr., Zwilling, B. S., Zbar, B., Rapp, H. J.: Regression of established intradermal tumors and lymph node metastases in guinea pigs after systemic transfer of immune lymphoid cells. J. Natl. Cancer Inst. 58, 1315 (1977)

    Google Scholar 

  20. Treves, A. J., Cohen, I. R., Feldman, M.: Immunotherapy of lethal metastases by lymphocytes sensitized against tumor cells in vitro. J. Natl. Cancer Inst. 54, 777 (1975)

    Google Scholar 

  21. Treves, A. J., Feldman, M., Kaplan, H. S.: In vitro sensitization of lymphocytes against histiocytic lymphoma cell lines. J. Immunol. 119, 955 (1977)

    Google Scholar 

  22. Treves, A. J., Feldman, M., Kaplan, H. S.: Cytotoxic activities of human lymphocytes against allogenic lymphoma cells. Program and Abstracts of the 12th International Leukocyte Culture Conference held in Beer Sheba, Israel, pp. 347 (1978)

  23. Wagner, H., Rollinghoff, M.: In vitro induction of tumor-specific immunity. J. Exp. Med. 138, 1 (1973)

    Google Scholar 

  24. Whitney, R. A., Levy, J. G., Smith, A. G.: Influence of tumor size and surgical reaction on cell-mediated immunity in mice. J. Natl. Cancer Inst. 53, 111 (1974)

    Google Scholar 

  25. Wong, A., Mankowitz, R., Kennedy, J. C.: Immunosuppressive and immunostimulating factors produced by malignant cells in vitro. Int. J. Cancer 13, 530 (1974)

    Google Scholar 

  26. Woodruff, J. F., Woodruff, J. J.: The effect of viral infections on the function of immune system. In: Viral immunology and immunopathology. New York: Academic Press (in Press) 1979

    CAS  PubMed  Google Scholar 

  27. Yu, A., Watts, H., Jaffé, N., Parkman, R.: Both inhibitor and cytotoxic lymphocytes in patients with osteogenic sarcoma. N. Engl. J. Med. 297, 121 (1977)

    Google Scholar 

  28. Zarling, J. M., Raich, P. C., McKeough, M., Bach, F. H.: Generation of cytotoxic lymphocytes in vitro against autologous human leukemia cells. Nature 262, 691 (1976)

    Google Scholar 

  29. Zolla, S.: The effect of plasmacytomas on the immune response of mice. J. Immunol. 108, 1039 (1972)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sharma, B., Odom, L.F. Generation of killer lymphocytes in vitro against human autologous leukemia cells with leukemic blasts and BCG extract. Cancer Immunol Immunother 7, 99–105 (1979). https://doi.org/10.1007/BF00205331

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00205331

Keywords

Navigation